Zeitlarn, Germany

Bernd Buchberger

This inventor holds 8 USPTO granted patents, plus 2 CIPO patents and 5 EPO patents. Top assignees: Hyglos Invest Gmbh, Biomérieux Deutschland Gmbh, Hypharm Gmbh. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernd Buchberger. Retrieved from https://idiyas.com/inventor/bernd-buchberger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Bernd Buchberger: Innovator in Recombinant Protein Production

Introduction

Bernd Buchberger is a notable inventor based in Zeitlarn/Laub, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of recombinant protein production. With a total of eight patents to his name, Buchberger's work has advanced the understanding and application of protein synthesis.

Latest Patents

One of Buchberger's latest patents is a method for the recombinant production of horseshoe crab Factor C protein in protozoa. This innovative method provides a novel approach to producing Factor C protein from horseshoe crabs using a parasitic protozoan that expresses the protein. The invention includes a parasitic protozoan host cell that harbors a polynucleotide encoding the horseshoe crab Factor C protein. The method involves culturing the protozoan host cell under specific conditions to ensure the expression of the Factor C protein. Additionally, the patent covers the recombinant Factor C protein produced by this method and its applications in the detection and removal of endotoxins.

Another significant patent by Buchberger focuses on unmasking endotoxins in solution. This invention relates to making previously undetectable endotoxins in compositions detectable. This advancement has important implications for various industries, particularly in pharmaceuticals and biotechnology.

Career Highlights

Throughout his career, Bernd Buchberger has worked with several companies, including Hyglos Invest GmbH and Hypharm GmbH. His experience in these organizations has contributed to his expertise in recombinant protein production and endotoxin detection.

Collaborations

Buchberger has collaborated with notable coworkers such as Sonja Molinaro and Anna Scherzinger. These partnerships have likely enhanced his research and development efforts in the field of biotechnology.

Conclusion

Bernd Buchberger's innovative work in recombinant protein production and endotoxin detection has made a significant impact in biotechnology. His patents reflect his commitment to advancing scientific knowledge and practical applications in this vital field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…